Category Archives: Bisphosphonates

Featured Stories

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Bisphosphonates Associated with Increased Risk of Atypical Hip Fractures, Researcher Says

The use of bisphosphonates, drugs prescribed to prevent hip fractures in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint. The research is contained in a PhD thesis by Javier Gorricho-Mendívil, at the NUP/UPNA-Public … Continue reading

Posted in Bisphosphonates, Fosamax, Health Concerns, Pharmaceuticals |

Study: Bisphosphonates Use Raises Risks for Atrial Fibrillation

bisphosphonate_atrial_fibrilation

New research has found that bisphosphonate use was tied to a significant increased risk of both atrial fibrillation (AF) and serious AF. Bisphosphonates include Fosamax (alendronate sodium), Reclast and Zometa (zoledronic acid), Boniva (ibandronate sodium), Didronel (etidronate disodium), Actonel (risedronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman Alleges Bisphosphonates Led to “Dead Jaw”

actonel_dead_jaw

We’ve long been following risks associated with bisphosphonate (BP) drugs like Fosamax, Boniva, and Actonel, which are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with Aredia, Zometa, and other bisphosphonate drugs … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Bisphosphonates Increase Bone Disease Risks Following Tooth Extraction

We’ve been following risks associated with bisphosphonate (BP) drugs. As we’ve explained, some bisphosphonates, like Fosamax, Boniva, and Actonel, are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients often undergo therapy with Aredia, Zometa, and other … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman who suffered jawbone loss due to Fosamax reaches damages settlement with Merck

A woman who claims her taking Fosamax in the prevention of bone loss caused by osteoporosis resulted in her developing decay of her jaw bone has reached a confidential settlement with the makers of the drug. Merck & Co. has … Continue reading

Posted in Bisphosphonates, Fosamax, Legal News, Pharmaceuticals | Tagged , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Study Finds Dental Work Triggers Bisphosphonate-Induced ONJ in Blood Cancer Patients

Dental extractions appear to be a major trigger for Ostenecrosis of the Jaw (ONJ) in people receiving bisphosphonates to treat multiple myeloma or Waldenstrom’s macroglobulinemia, says a new study out of Italy.  According to the authors of the report, which … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Rhode Island Woman’s Lawsuit Claims Fosamax Caused Painful Femur Fracture

Yet another woman who used Fosamax has filed a lawsuit claiming the bisphosphonate drug caused her to suffer a painful femur fracture.  This new lawsuit was filed on June 22nd in the Superior Court of New Jersey, Atlantic County Law … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Lawsuit Alleges Woman Suffered Femur Fracture Due to Fosamax

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of a woman who took Fosamax (alendronate) and subsequently suffered a femur fracture; the lawsuit alleges that Merck’s osteoporosis drug caused the fracture. The Fosamax lawsuit was filed … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.